
Viral infections affecting the lower respiratory tract place enormous burdens on hospitals. As neither vaccines nor anti-viral agents exist for many viruses, understanding risk factors and outcomes in each patient using minimally invasive analysis, such as blood, can lead to improved healthcare delivery. A cohort of PAXGene RNAseq of infants admitted with moderate or severe acute bronchiolitis and respiratory syncytial virus (RSV) were compared with case-control...
Like
Save
Share